SEC Filings | Y-mAbs Therapeutics, Inc.

Filing date	Description	Form	Filing Group	View
Jun 12, 2020	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	0001104659-20-073029.pdf 0001104659-20-073029.rtf 0001104659-20-073029.xls View HTML
Jun 05, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	0001104659-20-070319.pdf 0001104659-20-070319.rtf 0001104659-20-070319.xls View HTML
Jun 02, 2020	Report of unscheduled material events or corporate event	8-K	Current Reports	0001104659-20-068699.pdf 0001104659-20-068699.rtf 0001104659-20-068699.xls View HTML
May 29, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	0001104659-20-067768.pdf 0001104659-20-067768.rtf 0001104659-20-067768.xls View HTML
May 27, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	0001104659-20-066408.pdf 0001104659-20-066408.rtf 0001104659-20-066408.xls View HTML
May 20, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	0001104659-20-064263.pdf 0001104659-20-064263.rtf 0001104659-20-064263.xls View HTML
May 20, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	0001104659-20-064258.pdf 0001104659-20-064258.rtf 0001104659-20-064258.xls View HTML
May 15, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	0001104659-20-062623.pdf 0001104659-20-062623.rtf 0001104659-20-062623.xls View HTML
May 15, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	0001104659-20-062625.pdf 0001104659-20-062625.rtf 0001104659-20-062625.xls View HTML
May 15, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	0001104659-20-062619.pdf 0001104659-20-062619.rtf 0001104659-20-062619.xls View HTML

Data provided by Kaleidoscope.